A low CD4/CD8 ratio has been associated to AIDS and non-AIDS associated events. Long-term side effects have led to non-conventional NRTIsparing regimens. Aim of the study was to evaluate if the switch to mono/dual therapy could determine a change in CD4/CD8 ratio.
CD4/CD8 ratio in patients who switch cART therapy: triple drug regimen could be better than mono/dual?
G. Nunnari;G. F. Pellicanò.
2017-01-01
Abstract
A low CD4/CD8 ratio has been associated to AIDS and non-AIDS associated events. Long-term side effects have led to non-conventional NRTIsparing regimens. Aim of the study was to evaluate if the switch to mono/dual therapy could determine a change in CD4/CD8 ratio.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.